Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 639Head and Neck Neoplasms 612Carcinoma, Non-Small-Cell Lung 203Thyroid Neoplasms 199Melanoma 145Nasopharyngeal Carcinoma 136Oropharyngeal Neoplasms 130Colorectal Neoplasms 130Mouth Neoplasms 128Neoplasms 113Breast Neoplasms 113Lung Neoplasms 107Ovarian Neoplasms 105Uterine Cervical Neoplasms 100Neoplasm Metastasis 93Carcinoma, Squamous Cell 87Stomach Neoplasms 84Carcinoma, Renal Cell 83Triple Negative Breast Neoplasms 78Pancreatic Neoplasms 72Esophageal Neoplasms 70Laryngeal Neoplasms 68Endometrial Neoplasms 66Urinary Bladder Neoplasms 61Sarcoma 58Prostatic Neoplasms 55Thyroid Cancer, Papillary 54Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 46Carcinoma, Hepatocellular 45

Interventions

Iodine-123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignancy of Thyroid Nodules × Head & Neck × 1 year × Clear all
NCT03498183 2025-06-06

MIBI-THYR

Nantes University Hospital

Phase 2/3 Completed
372 enrolled
Head & Neck

Malignancy of Thyroid Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡